Yüklüyor......
The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
Effective treatments specific for COVID-19 are still lacking. In the setting of passive immunotherapies based on neutralizing antibodies (nAbs), randomized controlled trials of COVID-19 convalescent plasma (CCP) anti-SARS-CoV-2 Spike protein monoclonal antibodies (mAb), which have been granted emerg...
Kaydedildi:
| Yayımlandı: | Life (Basel) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7918959/ https://ncbi.nlm.nih.gov/pubmed/33671893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/life11020144 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|